Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Melanoma 1Liver Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 9Nivolumab 5aldesleukin 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Interleukin-2 2Cyclophosphamide 2Biopsy 2sargramostim 1relatlimab 1regorafenib 1prednylidene 1lutetium Lu 177 dotatate 1fludarabine phosphate 1fludarabine 1deltacortene 1avelumab 1aflibercept 1X-Rays 1Sirolimus 1Sentinel Lymph Node Biopsy 1Radiotherapy 1Prednisone 1Predictive Learning Models 1Paclitaxel 1Opdualag 1NEO212 1Lidocaine, Prilocaine Drug Combination 1Laparoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Merkel Cell × Administration, Cutaneous × Clear all
NCT06753136 2026-04-13

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Istituto Oncologico Veneto IRCCS

Phase NA Recruiting
24 enrolled
DermatologicGastrointestinal

Carcinoma, Squamous Cell, Liver Neoplasms, Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡